Despite President Trump’s recent executive push to move marijuana to Schedule III, a group of House Republicans is digging in for a high-stakes legislative battle. On April 30, 2026, the House Appropriations Subcommittee on Commerce, Justice, and Science took a bold stand by voting to block the funding required to finalize the reclassification.
This 8-6 party-line vote sets up a rare and public rift within the Republican party. While Trump has shifted toward a more moderate stance—emphasizing medical research and state-level sovereignty—hardliners in Congress remain steadfast. Led by figures like Rep. Andy Harris, these lawmakers argue that rescheduling would “normalize” the drug and lead to increased youth access. Their weapon of choice? Section 591, a budget provision designed to starve the Department of Justice of the funds needed to carry out the President’s directive.
The friction highlights a massive disconnect between the executive branch and the “Old Guard” of the GOP. While Trump’s order has already triggered legal shifts in several states, this funding roadblock could effectively freeze the federal transition in its tracks. As the bill heads to the full committee on May 13, the question remains: will the GOP follow their party leader toward reform, or will they successfully use the power of the purse to keep cannabis in the strictest tier of federal prohibition?
Dabbin-Dad Newsroom
